Skip to main content
    S

    SBC Medical Group Holdings Incorporated (SBC)

    Official site

    INDUSTRIALS • CONSULTING SERVICES • NASDAQ

    $6.18
    -1.17 (-15.92%)

    Market Cap: $755.92M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    SBC Medical Group Holdings Incorporated (SBC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect SBC Medical Group Holdings (SBC) to earn $0.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $190.98M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy133.3%
    Buy266.7%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 17.4% and revenue estimates rise 10.1%.

    Fiscal year ending Dec 31, 2026
    $0.46
    EPS consensus, revenue $190.98M
    Fiscal year ending Dec 31, 2027
    $0.54
    EPS consensus, revenue $210.35M
    Next report
    Mar 25, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.46$0.42 to $0.484$190.98M$182.51M to $197.85M5
    Dec 31, 2027$0.54$0.52 to $0.562$210.35M$192.40M to $222.58M4

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.12$0.10 to $0.146$52.04M$42.65M to $61.22M6

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202622
    Fiscal year ending Dec 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.1% from $0.47.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.46$0.46$0.46$0.46$0.47-1.1%
    Fiscal year ending Dec 31, 2027$0.54$0.54$0.54$0.54$0.49+11.3%

    Frequently Asked Questions About SBC

    What is the SBC stock forecast?

    Consensus analyst estimates put SBC Medical Group Holdings's EPS at $0.46 for the fiscal year ending Dec 31, 2026, on revenue of $190.98M. The consensus rating from 3 analysts is Buy.

    How do analysts rate SBC stock?

    Of 3 analysts covering SBC Medical Group Holdings, 1 rates it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SBC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.46, with estimates from $0.42 to $0.48 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.54, with estimates from $0.52 to $0.56 from 2 analysts.

    What revenue do analysts expect from SBC Medical Group Holdings next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $190.98M, with estimates from $182.51M to $197.85M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $210.35M, with estimates from $192.40M to $222.58M.

    How many analysts cover SBC?

    3 analysts rate SBC Medical Group Holdings stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.